Facts about DES & breast cancer

i

Facts about DES & breast cancer

Public Domain

2/26/04
By Centers for Disease Control and Prevention (U.S.)

File Language:

English

Details

Alternative Title:

Facts about DES and breast cancer
Corporate Authors:

Centers for Disease Control and Prevention (U.S.)
Description:

DES – a synthetic estrogen that was prescribed to pregnant women during 1938—1971 to prevent miscarriages or premature delivery – has been linked to several health risks. Included among these, is an increased risk of breast cancer among women who were prescribed DES while pregnant and DES Daughters – women who were exposed to DES in the womb.

Research available through CDC’s DES Update currently confirms the following facts pertaining to the affect of DES exposure on a woman’s risk for breast cancer.

Publication date from document properties.

DES&BreastCancerFS.pdf
Subjects:

Breast Neoplasms/chemically Induced Diethylstilbestrol/adverse Effects Pregnancy Prenatal Exposure Delayed Effects/chemically Induced
Document Type:

Pamphlet (or booklet)
Genre:

Fact Sheet
Pages in Document:

1 unnumbered page
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha256:f1355451de45fd8a7451c1047c75d7c5a8a0427024cace05bd13bd304b51fe82
Download URL:

https://stacks.cdc.gov/view/cdc/41052/cdc_41052_DS1.pdf
File Type:

[PDF - 16.67 KB ]

File Language:

English

ON THIS PAGE

Details

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.